Palisade Bio Inc (PALI)
6.30
-0.16
(-2.48%)
USD |
NASDAQ |
May 17, 16:00
6.30
0.00 (0.00%)
After-Hours: 20:00
Palisade Bio Free Cash Flow: -10.79M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.79M |
| December 31, 2023 | -11.13M |
| September 30, 2023 | -11.69M |
| June 30, 2023 | -12.07M |
| March 31, 2023 | -13.12M |
| Date | Value |
|---|---|
| December 31, 2022 | -13.36M |
| September 30, 2022 | -13.11M |
| June 30, 2022 | -12.82M |
| March 31, 2022 | -17.29M |
| December 31, 2021 | -14.77M |
Free Cash Flow Range, Past 5 Years
-17.29M
Minimum
Mar 2022
-10.79M
Maximum
Mar 2024
-13.02M
Average
-12.96M
Median
Free Cash Flow Benchmarks
| TG Therapeutics Inc | 20.28M |
| Protagenic Therapeutics Inc | -3.854M |
| Bio-Path Holdings Inc | -11.54M |
| Jaguar Health Inc | -30.34M |
| Finch Therapeutics Group Inc | -22.49M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.18M |
| Cash from Financing (Quarterly) | 2.024M |
| Free Cash Flow Per Share (Quarterly) | -4.140 |
| Free Cash Flow Yield | -294.5% |